Unnati Pharmax

Carbotero 450mg Injection
Composition: Carboplatin 450mg
International Trade Name: Paraplatin®

Carbotero 450 is a high-quality Carboplatin 450mg Injection, a trusted equivalent of the internationally recognized platinum-based chemotherapeutic agent marketed under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, Carbotero Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Carboplatin is a platinum coordination complex that inhibits DNA replication and transcription by forming DNA crosslinks, ultimately leading to apoptosis in rapidly dividing cancer cells. Carbotero 450mg Injection is primarily indicated for the treatment of ovarian cancer, lung cancer, head and neck cancers, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Carboplatin 450mg injection, Carbotero injection, Paraplatin equivalent, platinum-based chemotherapy, ovarian cancer treatment, lung cancer therapy, solid tumor chemotherapy, oncology injectable exporter India.

Carbotero 450 Carboplatin Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

WOMASTIN 450mg/45ml Injection
Composition: Carboplatin Injection IP 450mg
International Trade Name: Paraplatin®

WOMASTIN 450mg/45ml is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent, internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, WOMASTIN Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that disrupts DNA replication in cancer cells, inducing apoptosis. WOMASTIN 450mg/45ml Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 450mg injection, WOMASTIN injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

WOMASTIN 450mg/45ml Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CARBOLIEVA 450mg Injection
Composition: Carboplatin Injection IP 450mg
International Trade Name: Paraplatin®

CARBOLIEVA 450mg is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBOLIEVA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that inhibits DNA replication in cancer cells, leading to apoptosis. CARBOLIEVA 450mg Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 450mg injection, CARBOLIEVA injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBOLIEVA 450mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

INNOCAR 150 Injection
Composition: Carboplatin Injection IP 150mg
International Trade Name: Paraplatin®

INNOCAR 150 is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, INNOCAR Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that disrupts DNA replication in cancer cells, leading to apoptosis. INNOCAR 150 Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 150mg injection, INNOCAR injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

INNOCAR 150 Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CARBOLIEVA 150mg Injection
Composition: Carboplatin Injection IP 150mg
International Trade Name: Paraplatin®

CARBOLIEVA 150mg is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBOLIEVA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that inhibits DNA replication in cancer cells, leading to apoptosis. CARBOLIEVA 150mg Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 150mg injection, CARBOLIEVA injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBOLIEVA 150mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CARBOLIEVA 450mg Injection
Composition: Carboplatin Injection IP 450mg
International Trade Name: Paraplatin®

CARBOLIEVA 450mg is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBOLIEVA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that disrupts DNA replication in cancer cells, leading to apoptosis. CARBOLIEVA 450mg Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 450mg injection, CARBOLIEVA injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBOLIEVA 450mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Gembine 1000mg Injection
Composition: Gemcitabine 1000mg
International Trade Name: Gemzar®

Gembine 1000 is a high-quality Gemcitabine 1000mg Injection, a trusted equivalent of the internationally recognized nucleoside analog chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, Gembine Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Gemcitabine is a cytidine analog that inhibits DNA synthesis by incorporating into replicating DNA, leading to apoptosis of rapidly dividing cancer cells. Gembine 1000mg Injection is primarily indicated for the treatment of pancreatic cancer, non-small cell lung cancer, bladder cancer, breast cancer, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Gemcitabine 1000mg injection, Gembine injection, Gemzar equivalent, nucleoside analog chemotherapy, pancreatic cancer treatment, NSCLC therapy, breast and bladder cancer chemotherapy, oncology injectable exporter India.

Gembine 1000 Gemcitabine Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Gemtero 1gm Injection
Composition: Gemcitabine Injection 1gm
International Trade Name: Gemzar®

Gemtero 1gm is a premium Gemcitabine 1gm Injection, a high-quality formulation of the internationally recognized chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, Gemtero Injection is supplied by trusted pharmaceutical exporters from India to support advanced global oncology treatment programs, particularly for a wide range of solid tumors.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting the growth and proliferation of cancer cells. Gemtero 1gm Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 1gm injection, Gemtero 1gm injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, biologics exporter India, anticancer drug manufacturer India.

Gemtero 1gm Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

INNOGEM 1000 Injection
Composition: Gemcitabine Injection 1gm
International Trade Name: Gemzar®

INNOGEM 1000 is a high-quality Gemcitabine 1gm Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, INNOGEM Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. INNOGEM 1000 Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 1gm injection, INNOGEM injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

INNOGEM 1000 Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

INNOGEM 200 Injection
Composition: Gemcitabine Injection 200mg
International Trade Name: Gemzar®

INNOGEM 200 is a high-quality Gemcitabine 200mg Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, INNOGEM Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. INNOGEM 200 Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 200mg injection, INNOGEM injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

INNOGEM 200 Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

GEMLIEVA 1g Injection
Composition: Gemcitabine Injection 1g
International Trade Name: Gemzar®

GEMLIEVA 1g is a high-quality Gemcitabine 1g Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, GEMLIEVA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. GEMLIEVA 1g Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 1g injection, GEMLIEVA injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

GEMLIEVA 1g Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CISMAX 50mg Injection
Composition: Cisplatin Injection IP 50mg
International Trade Name: Platinol®

CISMAX 50mg is a high-quality Cisplatin 50mg Injection, a trusted platinum-based chemotherapeutic agent widely recognized under the brand name Platinol®. Manufactured in WHO-GMP certified facilities, CISMAX Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Cisplatin is a platinum-containing anticancer drug that works by forming DNA crosslinks, inhibiting cancer cell replication and inducing apoptosis. CISMAX 50mg Injection is primarily indicated for the treatment of various solid tumors, including testicular, ovarian, bladder, lung, and head & neck cancers, either as monotherapy or in combination with other anticancer agents.

Cisplatin 50mg injection, CISMAX injection, Platinol biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CISMAX 50mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

MELIEVA 2mg Tablets
Composition: Melphalan Tablets 2mg
International Trade Name: Alkeran®

MELIEVA 2mg is a high-quality Melphalan 2mg tablet, a widely trusted alkylating chemotherapeutic agent internationally recognized under the brand name Alkeran®. Manufactured in WHO-GMP certified facilities, MELIEVA Tablets are supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Melphalan is an alkylating agent that works by interfering with DNA replication and RNA transcription in cancer cells, leading to cell death. MELIEVA 2mg Tablets are primarily indicated for the treatment of multiple myeloma, ovarian cancer, and other hematologic or solid malignancies, either as monotherapy or in combination with other anticancer therapies.

Melphalan 2mg tablets, MELIEVA tablets, Alkeran biosimilar, alkylating chemotherapy, multiple myeloma treatment, oncology tablet, anticancer drug manufacturer India, pharmaceutical exporter India.

MELIEVA 2mg Tablets are manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The tablets are supplied in secure, export-grade packaging with complete regulatory documentation, making them suitable for hospitals, oncology clinics, government cancer programs, and international pharmaceutical distributors.

CARBYRA 150 Injection
Composition: Carboplatin Injection IP 150mg
International Trade Name: Paraplatin®

CARBYRA 150 is a high-quality Carboplatin 150mg Injection, a widely trusted platinum-based chemotherapeutic agent, internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBYRA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs globally.

Carboplatin is a platinum-containing anticancer drug that inhibits DNA replication in cancer cells, leading to apoptosis. CARBYRA 150 Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 150mg injection, CARBYRA injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBYRA 150 Injection is manufactured under strict GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Gemchem 1000mg Injection
Composition: Gemcitabine 1000mg
International Trade Name: Gemzar®

Gemchem 1000 is a high-quality Gemcitabine 1000mg Injection, a trusted equivalent of the internationally recognized nucleoside analog chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, Gemchem Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Gemcitabine is a cytidine analog that inhibits DNA synthesis by incorporating into replicating DNA, leading to apoptosis of rapidly dividing cancer cells. Gemchem 1000mg Injection is primarily indicated for the treatment of pancreatic cancer, non-small cell lung cancer, bladder cancer, breast cancer, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Gemcitabine 1000mg injection, Gemchem injection, Gemzar equivalent, nucleoside analog chemotherapy, pancreatic cancer treatment, NSCLC therapy, breast and bladder cancer chemotherapy, oncology injectable exporter India.

Gemchem 1000 Gemcitabine Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Gemchem 200mg Injection
Composition: Gemcitabine 200mg
International Trade Name: Gemzar®

Gemchem 200 is a high-quality Gemcitabine 200mg Injection, a trusted equivalent of the internationally recognized nucleoside analog chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, Gemchem Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Gemcitabine is a cytidine analog that inhibits DNA synthesis by incorporating into replicating DNA, leading to apoptosis of rapidly dividing cancer cells. Gemchem 200mg Injection is primarily indicated for the treatment of pancreatic cancer, non-small cell lung cancer, bladder cancer, breast cancer, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Gemcitabine 200mg injection, Gemchem injection, Gemzar equivalent, nucleoside analog chemotherapy, pancreatic cancer treatment, NSCLC therapy, breast and bladder cancer chemotherapy, oncology injectable exporter India.

Gemchem 200 Gemcitabine Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

GEMOLIFE NV 1000mg Injection
Composition: Gemcitabine Injection 1000mg
International Trade Name: Gemzar®

GEMOLIFE NV 1000mg is a high-quality Gemcitabine 1000mg Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, GEMOLIFE NV Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. GEMOLIFE NV 1000mg Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 1000mg injection, GEMOLIFE NV injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

GEMOLIFE NV 1000mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CYTOGEM 1000mg Injection
Composition: Gemcitabine Injection 1000mg
International Trade Name: Gemzar®

CYTOGEM 1000mg is a high-quality Gemcitabine 1000mg Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, CYTOGEM Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. CYTOGEM 1000mg Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 1000mg injection, CYTOGEM injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CYTOGEM 1000mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CARBYRA 450mg/45ml Injection
Composition: Carboplatin Injection IP 450mg
International Trade Name: Paraplatin®

CARBYRA 450mg/45ml is a premium Carboplatin Injection, a widely trusted platinum-based chemotherapeutic agent, internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBYRA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs globally.

Carboplatin is a platinum-containing anticancer drug that inhibits DNA replication in cancer cells, leading to apoptosis. CARBYRA 450mg/45ml Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 450mg injection, CARBYRA injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBYRA 450mg/45ml Injection is manufactured under strict GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

GEMTYRA-RTU 1000mg Injection
Composition: Gemcitabine 1000mg
International Trade Name: Gemzar®

GEMTYRA-RTU 1000 is a high-quality Gemcitabine 1000mg Injection, a ready-to-use formulation and trusted equivalent of the internationally recognized nucleoside analog chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, GEMTYRA-RTU Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Gemcitabine is a cytidine analog that inhibits DNA synthesis by incorporating into replicating DNA, leading to apoptosis of rapidly dividing cancer cells. GEMTYRA-RTU 1000mg Injection is primarily indicated for the treatment of pancreatic cancer, non-small cell lung cancer, bladder cancer, breast cancer, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Gemcitabine 1000mg injection, GEMTYRA-RTU injection, Gemzar equivalent, nucleoside analog chemotherapy, pancreatic cancer treatment, NSCLC therapy, breast and bladder cancer chemotherapy, oncology injectable exporter India.

GEMTYRA-RTU 1000 Gemcitabine Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, ready-to-use, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

GEMTYRA-RTU 200mg Injection
Composition: Gemcitabine Injection 200mg
International Trade Name: Gemzar®

GEMTYRA-RTU 200mg is a high-quality Gemcitabine 200mg Injection, a biosimilar of the internationally recognized chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, GEMTYRA-RTU Injection is supplied by trusted pharmaceutical exporters from India to support comprehensive global oncology treatment programs.

Gemcitabine is a nucleoside analog that disrupts DNA synthesis, inhibiting cancer cell growth and proliferation. GEMTYRA-RTU 200mg Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as a standalone therapy or in combination with other anticancer agents.

Gemcitabine 200mg injection, GEMTYRA-RTU injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

GEMTYRA-RTU 200mg Injection is manufactured under strict GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it ideal for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

GEMILEVA 200mg Injection
Composition: Gemcitabine Injection 200mg
International Trade Name: Gemzar®

GEMILEVA 200mg is a high-quality Gemcitabine 200mg Injection, a trusted chemotherapeutic agent widely recognized under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, GEMILEVA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Gemcitabine is a nucleoside analog that interferes with DNA synthesis, effectively inhibiting cancer cell growth and proliferation. GEMILEVA 200mg Injection is primarily indicated for the treatment of various malignancies, including pancreatic cancer, non-small cell lung cancer (NSCLC), bladder cancer, breast cancer, and ovarian cancer, either as monotherapy or in combination with other anticancer agents.

Gemcitabine 200mg injection, GEMILEVA injection, Gemzar biosimilar, nucleoside analog chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

GEMILEVA 200mg Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CISPLYRA 50 Injection
Composition: Cisplatin Injection IP 50mg
International Trade Name: Platinol®

CISPLYRA 50 is a high-quality Cisplatin 50mg Injection, a trusted chemotherapeutic agent widely recognized under the brand name Platinol®. Manufactured in WHO-GMP certified facilities, CISPLYRA Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Cisplatin is a platinum-based chemotherapeutic agent that works by forming DNA crosslinks, inhibiting cancer cell replication and inducing apoptosis. CISPLYRA 50 Injection is primarily indicated for the treatment of various solid tumors, including testicular, ovarian, bladder, lung, and head & neck cancers, either as monotherapy or in combination with other anticancer agents.

Cisplatin 50mg injection, CISPLYRA injection, Platinol biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CISPLYRA 50 Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

CARBOKAST 450 Injection
Composition: Carboplatin Injection IP 450mg
International Trade Name: Paraplatin®

CARBOKAST 450 is a premium Carboplatin Injection, a trusted platinum-based chemotherapeutic agent internationally recognized under the brand name Paraplatin®. Manufactured in WHO-GMP certified facilities, CARBOKAST Injection is supplied by reputable pharmaceutical exporters from India to support advanced oncology treatment programs worldwide.

Carboplatin is a platinum-containing anticancer drug that disrupts DNA replication in cancer cells, leading to apoptosis. CARBOKAST 450 Injection is primarily indicated for the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancers, and other platinum-sensitive malignancies, either as monotherapy or in combination with other chemotherapeutic agents.

Carboplatin 450mg injection, CARBOKAST injection, Paraplatin biosimilar, platinum-based chemotherapy, solid tumor treatment, oncology injection, anticancer drug manufacturer India, biologics exporter India.

CARBOKAST 450 Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.

Gemchem 1400mg Injection
Composition: Gemcitabine 1400mg
International Trade Name: Gemzar®

Gemchem 1400 is a high-quality Gemcitabine 1400mg Injection, a trusted equivalent of the internationally recognized nucleoside analog chemotherapeutic agent marketed under the brand name Gemzar®. Manufactured in WHO-GMP certified facilities, Gemchem Injection is supplied by reputable pharmaceutical exporters from India to support advanced global oncology treatment programs.

Gemcitabine is a cytidine analog that inhibits DNA synthesis by incorporating into replicating DNA, leading to apoptosis of rapidly dividing cancer cells. Gemchem 1400mg Injection is primarily indicated for the treatment of pancreatic cancer, non-small cell lung cancer, bladder cancer, breast cancer, and other approved solid tumors, either as monotherapy or in combination chemotherapy regimens.

Keywords: Gemcitabine 1400mg injection, Gemchem injection, Gemzar equivalent, nucleoside analog chemotherapy, pancreatic cancer treatment, NSCLC therapy, breast and bladder cancer chemotherapy, oncology injectable exporter India.

Gemchem 1400 Gemcitabine Injection is manufactured under stringent GMP and quality standards, ensuring consistent efficacy, safety, and long-term stability. The injection is supplied in secure, cold-chain compliant, export-grade packaging with complete regulatory documentation, making it suitable for oncology infusion centers, tertiary care hospitals, government cancer programs, and international pharmaceutical distributors.